Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma

BMC Cancer

Table 1 Distribution of characteristics of two independent patient cohorts with RCC by FBXO11 expression

Patient characteristics	Training cohort (150 patients)		Total	P Value	Validation cohort (77patients)		Total	P Value
Patient characteristics	Low	High	Total	P Value	Low	High	Total	P Value
Gender				0.227				0.644
Male	41	63	104		17	25	42
Female	23	23	46		16	19	35
Age, years				0.048				0.099
<57	38	37	75		19	17	36
≥57	26	49	75		14	27	41
Tumor size				0.738				0.394
≤4 cm	30	35	65		15	14	29
4 cm–7 cm	24	35	59		13	24	37
≥7 cm	10	16	26		5	6	11
Fuhrman grade				0.003				0.111
I-II	47	39	86		22	19	41
III	14	37	51		8	16	24
IV	3	10	13		3	9	12
Pathologic stage				0.065				0.291
T1	58	66	124		28	29	57
T2	5	13	18		2	8	10
T3	1	7	8		2	5	7
T4	0	0	0		1	2	3
Lymph node status				0.764				0.423
No	62	84	146		31	39	70
N1- Nx	2	5	4		2	5	7
Distant metastasis				0.131				0.894
Absent	64	83	147		31	41	72
Present	0	3	3		2	3	5
Sarcomatoid				0.846				0.894
Absent	59	80	139		31	41	72
Present	5	6	11		2	3	5
Type of surgery				0.395				0.836
Radical nephrectomy	42	62	104		21	29	50
Partial nephrectomy.	22	24	46		12	15	27
UISS score				0.021				0.012
1	52	52	104		26	20	46
2	11	29	40		7	23	30
3	1	5	6		0	1	1
SSIGN score				0.205				0.070
0–3	58	70	128		27	26	53
4–7	6	14	20		3	13	16
≥8	3	5	8		3	5	8

ISSN: 1471-2407